The impacts of SARS-CoV-2 vaccine dose separation and targeting on the COVID-19 epidemic in England.

Keeling, Matt J; Moore, Samuel; Penman, Bridget S; Hill, Edward M

Keeling, Matt J; Moore, Samuel; Penman, Bridget S; Hill, Edward M.

Afiliação

Keeling MJ; The Zeeman Institute for Systems Biology & Infectious Disease Epidemiology Research, University of Warwick, Coventry, CV4 7AL, UK. M.J.Keeling@warwick.ac.uk.
Moore S; Joint UNIversities Pandemic and Epidemiological Research, . M.J.Keeling@warwick.ac.uk.
Penman BS; Joint UNIversities Pandemic and Epidemiological Research.
Hill EM; Lancaster Medical School, Lancaster University, Lancaster, LA1 4YW, UK.

Nat Commun ; 14(1): 740, 2023 02 10.

Article em En | MEDLINE | ID: mdl-36765050

Assuntos

COVID-19; Epidemias; Humanos; Vacinas contra COVID-19; COVID-19/epidemiologia; COVID-19/prevenção & controle; SARS-CoV-2; Inglaterra/epidemiologia; Epidemias/prevenção & controle; Vacinação

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Epidemias / COVID-19 Limite: Humans País/Região como assunto: Europa Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google